Search results

This article proposes that survival can be a legitimate organizational goal, challenging a common view that dismisses it as unambitious or contrary to innovation. Drawing parallels from nature and survival strategies across various systems, it advocates that organizations, much like living organisms, should prioritize survivability (i.e. ability to survive) to ensure long-term success. Contrary to being seen as limiting, survival, when understood in its broad sense, can encompass and enhance performance goals such as growth. The article outlines the ERP factors —efficiency, resilience and prominence—as key to achieving survivability, offering a framework for organizations to manage resources, adapt to external forces and balance visibility to thrive amidst challenges.

Conceptual framework.

This model introduces the significance of survivability as an organizational goal.

This article argues for the consideration of survival as an overarching organizational goal, challenging the prevalent view that dismisses it as unambitious or contrary to innovation.

The study discusses a rationale for a new type of capability called supply chain immunity that is required to address slow-moving, persistent and dispersed pandemics similar to COVID-19 in the future. The authors’ work on the COVID-19 emergency response suggests flaws in the medical and healthcare supply chain systems, due to reliance on overseas manufacturing and insufficient strategic stockpile.

In seeking to understand the characteristics of supply chain immunity and how it is related to the need for a renewed strategic national stockpile, the authors adopted an inductive observational approach of engaged scholarship, based on their team’s extensive involvement in the national COVID-19 healthcare response during March–June 2020.

The study analysis, based on visibility, velocity and global independence, establishes a new type of supply chain immunity, along with the requirements for development of this capability. The framework for immunity proposed in this article provides general guidelines that an emergency responder would probably use in an informal fashion. The immunity framework is validated through references to current work on COVID-19 supply chain preparedness.

The understanding of readiness for pandemic operations using the metaphor of supply chain immunity is unique. It contains important observations on the development of capabilities – specifically, the outcome of an aligned medical and supply chain intelligence, a clinical standards organization and a materials management monitoring system. The authors’ insights are supported not only by literature but also due to direct engagement with academic scholars, Department of Defense (DoD) personnel, supply risk platforms and government officials involved in the COVID-19 pandemic response.

The authors identify the critical bottlenecks that exist in the vaccine supply chain that are preventing a robust coronavirus disease (COVID) response. The authors posit that improved supply chain signals can result in improved handling and distribution of vaccines in a post-COVID world and identify recommendations for redesign of the vaccine supply chain as well as future research questions for scholars.

The supply chain operating reference (SCOR) model is used as a framework to identify each of the major gaps that exist in the supply chain for the COVID vaccine. The critical bottlenecks and delays that exist within this supply chain are identified through this framework and validated through the ongoing research and interviews in the field.

Whilst the vaccine supply chain for influenza is perfectly sized for development and distribution of this cyclical virus, the emergence of a new virus created a pandemic, which has exposed a number of critical shortages. The authors find that the design of the COVID vaccine supply chain suffers from a flawed structure. To date, less than 3% of the United States and global population has been fully vaccinated. The authors advocate a “back to front design”, beginning with demand planning for actual vaccinations and working backwards toward supply planning and distribution planning. These lessons may be helpful for capacity planning and supply chain strategy for future vaccinations as variants of the COVID vaccine emerge.

The authors provide a unique approach for viewing the current shortages that exist in the vaccine supply chain and offer suggestions for new variants of this supply chain for the future.

This study examines the lack of confidence in the actions of the government and pharmaceutical companies during vaccine deployment. The authors introduce the concept of supply chain immunity. The authors test whether the perception of higher vaccine supply chain immunity leads to higher willingness to be vaccinated within the supply chain community.

The authors utilize factor analysis and item response theory methods to develop a scale for measuring supply chain immunity. The original and psychometrically sound scale is tested via a structural equation model (SEM). Factor analysis and SEM use survey responses from two samples of 125 supply chain executives.

SEM suggests that supply chain immunity perceptions are a strong predictor of overall supply chain confidence for COVID vaccines. Further, these perceptions, through supply chain confidence, indirectly impact individuals' self-reported willingness to personally accept a vaccine themselves.

This paper presents the concept of supply chain immunity perceptions that have not been used in the medical supply chain literature. This paper presents a first-of-a-kind scale for supply chain immunity perceptions utilizing nascent methods and demonstrates the constructs impact on vaccine program confidence and public willingness to participate.

This study aims to analyze the epidemic modeling applications and policy‐making strategies for six different infectious diseases in a number of countries, thus comparing and contrasting research in underdeveloped, developing, and developed countries.

A systematic review has been conducted by identifying relevant studies for six diseases from different sources and selecting 74 publications for inclusion. These selected publications are classified and analyzed based on infectious disease, control policies, theme and objective, methodology, origin of population data, publication year and results.

Review results indicate that disaster preparedness and surveillance plans for epidemics are available mostly for developed countries. There is a need for further research in both developing and developed countries because of the ease of dispersion, which constitutes a universal threat. Analysis of the publications suggests that epidemic disasters are mostly studied by researchers in the field of medicine or biology with the aim of assessing the potential impact of an epidemic. The authors highlight the need for further research in operations research and disaster management fields and propose further research directions in the area of disaster management.

This review emphasizes the importance of epidemic disaster modeling for the preparedness stage of disaster management and policy making. Disease and population‐specific intervention policies (e.g. vaccination) reported in this review should set an example and help policy makers during their decision making.

Potential use of the epidemiological modeling on further planning and decision‐making issues in the context of disaster management is studied for the first time.

The purpose of this study is to carry out an investigation of the role of the wood particle size on the mechanical properties of poly lactic acid (PLA)-reinforced neem fiber biocomposite.

Composite test specimens were processed by reinforcing neem wood flour (NWF) in two different particle sizes, micro-sized NWF (MNWF) and nano-sized NWF (NNWF) separately into PLA. Composites were extruded at four different fiber loadings (10, 15, 20 and 25 Wt.%) into PLA matrix. The MNWF and NNWF had particle sizes varying from 5 to 15 µm and 10 to 15 nm, respectively.

Tensile strength, flexural strength and impact strength of PLA increased with fiber reinforcement for both the MNWF and NNWF cases. The NNWF-reinforced PLA composite at 20 Wt.% fiber loading proved to be the best composite that had outstanding mechanical properties in this research.

The developed composite can be used as a substitute for conventional plywood for furniture, building infrastructure and interior components for the automobile, aircraft and railway sectors.

A new biocomposite had been fabricated by using PLA and NWF and had been tested for its mechanical characteristics.